Cargando…

Does reductio ad absurdum have a place in evidence-based medicine?

In a meta-analysis published in BMC Medicine, we explored whether evidence-based medicine can actually be sure that ‘sucrose = sucrose’ in the treatment of depression. This paper, based upon a reductio ad absurdum, addressed an epistemological question using a ‘scientific’ approach, and could be dis...

Descripción completa

Detalles Bibliográficos
Autores principales: Naudet, Florian, Falissard, Bruno
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4070092/
https://www.ncbi.nlm.nih.gov/pubmed/24962765
http://dx.doi.org/10.1186/1741-7015-12-106
_version_ 1782322640313122816
author Naudet, Florian
Falissard, Bruno
author_facet Naudet, Florian
Falissard, Bruno
author_sort Naudet, Florian
collection PubMed
description In a meta-analysis published in BMC Medicine, we explored whether evidence-based medicine can actually be sure that ‘sucrose = sucrose’ in the treatment of depression. This paper, based upon a reductio ad absurdum, addressed an epistemological question using a ‘scientific’ approach, and could be disconcerting as suggested by Cipriani and Geddes’ commentary. However, most papers are based upon a mixture of observations and discussions about sense and meaning. Ultimately, there is nothing more than a story, told with words or numbers. Randomised controlled trials provide information about average patients that do not exist. These results ignores an entire segment of therapeutics that plays a crucial role, namely care. This information is usually set out using a ‘grammar’ that is ambiguous, since statistical tests of hypothesis have raised epistemological questions that are not as yet solved. Moreover, many of these stories remain untold, and unpublished. For these reasons evidence-based medicine is a vehicle for many paradoxes and controversies. Reductio ad absurdum can be useful in precisely this case, to underline how and why the medical literature can sometimes give an impression of absurdity of this sort. Even if the data analysis in our paper was rather rhetorical, we agree that it should comply with the classic standards of reporting and we provide the important extra data that Cipriani and Geddes have requested. Please see related articles: http://www.biomedcentral.com/1741-7015/11/230 and http://www.biomedcentral.com/1741-7015/12/105.
format Online
Article
Text
id pubmed-4070092
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-40700922014-06-26 Does reductio ad absurdum have a place in evidence-based medicine? Naudet, Florian Falissard, Bruno BMC Med Comment In a meta-analysis published in BMC Medicine, we explored whether evidence-based medicine can actually be sure that ‘sucrose = sucrose’ in the treatment of depression. This paper, based upon a reductio ad absurdum, addressed an epistemological question using a ‘scientific’ approach, and could be disconcerting as suggested by Cipriani and Geddes’ commentary. However, most papers are based upon a mixture of observations and discussions about sense and meaning. Ultimately, there is nothing more than a story, told with words or numbers. Randomised controlled trials provide information about average patients that do not exist. These results ignores an entire segment of therapeutics that plays a crucial role, namely care. This information is usually set out using a ‘grammar’ that is ambiguous, since statistical tests of hypothesis have raised epistemological questions that are not as yet solved. Moreover, many of these stories remain untold, and unpublished. For these reasons evidence-based medicine is a vehicle for many paradoxes and controversies. Reductio ad absurdum can be useful in precisely this case, to underline how and why the medical literature can sometimes give an impression of absurdity of this sort. Even if the data analysis in our paper was rather rhetorical, we agree that it should comply with the classic standards of reporting and we provide the important extra data that Cipriani and Geddes have requested. Please see related articles: http://www.biomedcentral.com/1741-7015/11/230 and http://www.biomedcentral.com/1741-7015/12/105. BioMed Central 2014-06-25 /pmc/articles/PMC4070092/ /pubmed/24962765 http://dx.doi.org/10.1186/1741-7015-12-106 Text en Copyright © 2014 Naudet and Falissard; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Comment
Naudet, Florian
Falissard, Bruno
Does reductio ad absurdum have a place in evidence-based medicine?
title Does reductio ad absurdum have a place in evidence-based medicine?
title_full Does reductio ad absurdum have a place in evidence-based medicine?
title_fullStr Does reductio ad absurdum have a place in evidence-based medicine?
title_full_unstemmed Does reductio ad absurdum have a place in evidence-based medicine?
title_short Does reductio ad absurdum have a place in evidence-based medicine?
title_sort does reductio ad absurdum have a place in evidence-based medicine?
topic Comment
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4070092/
https://www.ncbi.nlm.nih.gov/pubmed/24962765
http://dx.doi.org/10.1186/1741-7015-12-106
work_keys_str_mv AT naudetflorian doesreductioadabsurdumhaveaplaceinevidencebasedmedicine
AT falissardbruno doesreductioadabsurdumhaveaplaceinevidencebasedmedicine